FDA Inspection 1208271 — Dean L. Harris
The FDA completed an inspection of Dean L. Harris on May 5, 2023 in Christchurch. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- May 5, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Christchurch (New Zealand)
Additional Details
Clinical Investigator (CI)